benlysta
July 20th, 2009
Benlysta is an experimental lupus (Any of several forms of ulcerative skin disease) drug which produced positive consequences in a company-backed study has. Editor's Note: The report mentioned in the fifth paragraph came from Lazard Capital Markets, not Lazard Freres, as previously reported.The experimental lupus drug Benlysta has defied skeptics by significantly improving the symptoms of Here's one that is not only a milestone for HGSI, but for patients with lupus. Human Genome Sciences Inc. (HGSI) and GlaxoSmithKline (GSK) announced just after.